Prosecution Insights
Last updated: April 19, 2026

Conagen Inc.

6 pending office actions

Portfolio Summary

6
Total Pending OAs
1
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18483622 BIOSYNTHETIC PRODUCTION OF STEVIOL GLYCOSIDES MCINTOSH III, TRAVISS C 1693 Non-Final OA Oct 10, 2023
18449008 MICROBIAL ERGOTHIONEINE BIOSYNTHESIS SAIDHA, TEKCHAND 1652 Non-Final OA Aug 14, 2023
18052595 PRODUCTION OF NMN AND ITS DERIVATIVES VIA MICROBIAL PROCESSES LYONS, MARY M 1645 Non-Final OA Nov 04, 2022
17820921 NON-CALORIC SWEETENERS AND METHODS FOR SYNTHESIZING EDWARDS, JESSICA FAYE 1657 Final Rejection Aug 19, 2022
17712452 BIOSYNTHESIS OF ALPHA-IONONE AND BETA-IONONE PAULUS, ERIN VIRGINIA 1631 Non-Final OA Apr 04, 2022
17697043 BIOSYNTHETIC PRODUCTION OF STEVIOL GLYCOSIDE REBAUDIOSIDE D4 FROM REBAUDIOSIDE E NOAKES, SUZANNE MARIE 1656 Non-Final OA Mar 17, 2022

Managing Conagen Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month